FDA: In-Vitro Alcohol testing of modified release product [Regulatives / Guidelines]

posted by Shuanghe  – Spain, 2012-05-17 12:08 (5138 d 19:31 ago) – Posting: # 8579
Views: 2,394

❝ Is it required to compare against the reference product? If so, is it based on f2?


yes. If you go to FDA's guidance page looking for new individual BE guidance for MR product, almost all of them require this test and:

"Both test and reference listed drug (RLD) products should be tested accordingly and data should be provided on individual unit, means, range and %CV on all strengths."

❝ If the rate of in-vitro release in EtOH is not similar (i.e., faster but not the point of dose dumping) to that of the reference, then what?


check this link.

http://www.aapsj.org/abstracts/am_2008/aaps2008-001832.pdf

I hope this helps.

Shuanghe

All the best,
Shuanghe

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
151 visitors (0 registered, 151 guests [including 23 identified bots]).
Forum time: 07:40 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5